Norepinephrine Final
Norepinephrine Final
DRUG STUDY
DRUG NAME DRUG MODE OF ACTION SIDE EFFECTS AND CONTRAINDICATION NURSING
(Generic CLASSIFICATION ADVERSE REACTIONS MANAGEMENT/
Name, Brand Name, CONSIDERATION
Dose, Route, Dosage)
Generic Name: Vasopressor • Stimulates alpha- Cardiovascular • Hypersensitivity to • Monitor the patient
Norepinephrine adrenergic receptors in bisulfites constantly when
the blood vessels • Arrhythmias • Vascular, mesenteric or norepinephrine is
Brand Name: which causes peripheral thrombosis administered. Before the
Levophed constriction of • Hypotension secondary to • Hypoxia start of therapy, the
capacitance and • Hypercabia baseline pulse and BP
hypovolemia
Dose: resistance vessels thus • Hypotension secondary must be taken, then start
8mg to hypovolemia by giving 10 microdrops
increasing blood • Blue lips or fingernails per minute to uptitrate 5
pressure and cardiac
Route: microdrops per minute
output. • Hypercabia to achieve desired BP.
IV
• Adjust flow rate to
• Vascular, mesenteric or maintain normal blood
Dosage:
peripheral thrombosis pressure.
8mg diluted in 125 mL • Observe the mental
per soluset. status, skin temperature
10 microdrops per of extremities, and color
minute to uptitrate 5
CNS/PNS (earlobes, lips, nail beds)
microdrop per minute in addition to vital signs.
• Monitor input and
• Headache
output.
• Be alert when patient
• Nausea and vomiting complains about
headache, vomiting,
• Tremor palpitation, arrhythmias,
chest pain, photophobia,
and blurry visions as
these are possible signs
• Restlessness of overdosage.
• Continue monitoring
• Weakness vital signs and observe
patient closely after the
end of therapy for
• Dizziness
clinical sign of
circulatory inadequacy.
• Seizure • Continuously monitor
ECG during drug
• Confusion administration.
• Assess for paresthesia
and coldness of
extremities, peripheral
Urogenital blood flow may
decrease.
• Urinary retention
Respiratory
• Trouble breathing
• Hypoxia
• Dyspnea